Post COVID-19 Supply Chain Optimization for the Indian Pharmaceutical Industry using AI Techniques
Abstract
The COVID-19 pandemic has overwhelmed healthcare systems around the globe, having an indirect effect on the treatment of other diseases. During these unprecedented times the Indian pharmaceutical industry has been busy responding to all the sudden healthcare challenges that were arising from the disruption in supply chains, and this has showcased a necessity to improve functioning of the industry. Overall, India is one the fastest emerging pharmaceutical markets but many faults from the past decade in the Indian supply chain system have been highlighted by this pandemic. This paper discusses the critical elements of any supply chain and the various strategies that a pharmaceutical company can use to function efficiently. Some of the more modern approaches used by companies are artificial intelligence (AI) and machine learning (ML) tools in supply chain optimization. These new technologies help reduce lead times, significantly lower costs and help predict better routes for the future. The paper then analyzes an active pharmaceutical ingredient (API), paracetamol which is a highly produced drug in India. Evaluating its current production in the supply chain process, the paper suggests ways to improve supply chain for this particular API in India. All in all, improving the supply chain management in India by developing coherent strategies and making data-driven decisions has the potential to improve organizational profitability.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Intersect: The Stanford Journal of Science, Technology, and Society

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).